To the best of our knowledge, this is the first study to elaborate the potential interplay between the 21-gene RS and comprehensive metabolic profiles including common metabolic disorders and insulin and the IGF axis biomarkers in relation to the risk of breast cancer recurrence. This evidence concerns the gene INS and breast carcinoma.